GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

USB · Sep 30, 2025

US BANCORP DE. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000036104-25-000064Bank
Sequential deposit growth79thOwn-history percentile · N=14
Evidence method

Sequential · gp.financial.deposits

1.43% · CORE · VALID

Net-income growth82thOwn-history percentile · N=11
Evidence method

Yoy · gp.fundamentals.net_income

16.74% · CORE · VALID

Interest-income growth18thOwn-history percentile · N=11
Evidence method

Yoy · gp.financial.interest_income

-1.97% · CORE · VALID

Cash and equivalents79thOwn-history percentile · N=14
Evidence method

Level · gp.fundamentals.cash

$66.6B · CORE · VALID

Sequential loan growth64thOwn-history percentile · N=14
Evidence method

Sequential · gp.financial.loans

0.60% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History18 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
1.21%
Current
1.43%
Delta
0.22%
Earnings Growth Increased
Previous
13.23%
Current
16.74%
Delta
3.52%
Interest Income Growth Increased
Previous
-4.77%
Current
-1.97%
Delta
2.81%
Liquidity Increased
Previous
$57.8B
Current
$66.6B
Delta
$8.8B
Loan Growth Increased
Previous
-0.41%
Current
0.60%
Delta
1.01%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.